Advertisement

week in cancer news

  • October 11: The Week in Cancer News

    A researcher with melanoma writes about his experiences trying to modify his gut microbiome, and an article discusses what it means to call a cancer treatment “well tolerated.”

    by Kate Yandell

  • October 4: The Week in Cancer News

    More than half of patients with advanced melanoma who took an immunotherapy combination were alive five years later, and a targeted therapy appears to cause high blood pressure.

    by Kate Yandell

  • September 27: The Week in Cancer News

    A study examines how poor and minority patients are more likely to be diagnosed with cancer in the emergency room, and a cancer survivor considers the lasting effects of chemotherapy.

    by Bradley Jones

  • September 20: Week in Cancer News

    Article describes efforts to support cancer survivors, radiation meeting focuses on treatment de-escalation, and studies show that brain tumor cells have their own neural network.

    by Marci A. Landsmann

  • September 13: The Week in Cancer News

    Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.

    by Kate Yandell

  • September 6: The Week in Cancer News

    Organizations release guidelines on reducing breast cancer risk using medications, and a palliative care doctor discusses the pros and cons of dying at home.

    by Kate Yandell

  • August 30: The Week in Cancer News

    A study looks at hormone therapy and breast cancer risk, and researchers take a closer look at marijuana use in young cancer patients.

    by Marci A. Landsmann

  • August 23: The Week in Cancer News

    Recommendations say that a broader group of women should be considered for BRCA mutation testing, and the U.S. Food and Drug Administration issues a proposal to require that cigarettes come with graphic warnings.

    by Kate Yandell

  • August 16: The Week in Cancer News

    A radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.

    by Kate Yandell

  • August 9: The Week in Cancer News

    A liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.

    by Kevin McLaughlin

Advertisement
Advertisement

From the AACR

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR